BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28284262)

  • 1. Respiratory medication use in primary care among COPD subjects in four Latin American countries.
    Jardim JR; Stirbulov R; Moreno D; Zabert G; Lopez-Varela MV; Montes de Oca M
    Int J Tuberc Lung Dis; 2017 Apr; 21(4):458-465. PubMed ID: 28284262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchodilator treatment for COPD in primary care of four Latin America countries: The multinational, cross-sectional, non-interventional PUMA study.
    Montes de Oca M; Lopez Varela MV; Jardim J; Stirvulov R; Surmont F
    Pulm Pharmacol Ther; 2016 Jun; 38():10-6. PubMed ID: 27113029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study.
    Montes de Oca M; Victorina Lopez Varela M; Laucho-Contreras ME; Casas A; Schiavi E; Mora JC
    BMC Pulm Med; 2017 Apr; 17(1):69. PubMed ID: 28431499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COPD Underdiagnosis and Misdiagnosis in a High-Risk Primary Care Population in Four Latin American Countries. A Key to Enhance Disease Diagnosis: The PUMA Study.
    Casas Herrera A; Montes de Oca M; López Varela MV; Aguirre C; Schiavi E; Jardim JR;
    PLoS One; 2016; 11(4):e0152266. PubMed ID: 27073880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a simple screening tool for opportunistic COPD case finding in primary care in Latin America: The PUMA study.
    López Varela MV; Montes de Oca M; Rey A; Casas A; Stirbulov R; Di Boscio V;
    Respirology; 2016 Oct; 21(7):1227-34. PubMed ID: 27319305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of respiratory medication in five Latin American cities: The PLATINO study.
    Montes de Oca M; Tálamo C; Perez-Padilla R; Lopez MV; Muiño A; Jardim JR; Valdivia G; Pertuzé J; Moreno D; Halbert RJ; Menezes AM;
    Pulm Pharmacol Ther; 2008 Oct; 21(5):788-93. PubMed ID: 18621136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.
    Montes de Oca M; Aguirre C; Lopez Varela MV; Laucho-Contreras ME; Casas A; Surmont F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3059-3067. PubMed ID: 27994446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of the PUMA COPD diagnostic questionnaire in a general practice sample and the PLATINO study population.
    Lopez Varela MV; Montes de Oca M; Wehrmeister FC; Rodriguez C; Ramirez L; Menezes A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1901-1911. PubMed ID: 31692595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of undertreatment in COPD in the general population.
    Ingebrigtsen TS; Marott JL; Vestbo J; Hallas J; Nordestgaard BG; Dahl M; Lange P
    Chest; 2013 Dec; 144(6):1811-1818. PubMed ID: 23989916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre- and post-bronchodilator airway obstruction are associated with similar clinical characteristics but different prognosis - report from a population-based study.
    Sawalha S; Hedman L; Rönmark E; Lundbäck B; Lindberg A
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1269-1277. PubMed ID: 28490870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inaccurate diagnosis of COPD: the Welsh National COPD Audit.
    Fisk M; McMillan V; Brown J; Holzhauer-Barrie J; Khan MS; Baxter N; Roberts CM
    Br J Gen Pract; 2019 Jan; 69(678):e1-e7. PubMed ID: 30559109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings.
    Martinez FJ; Han MK; Lopez C; Murray S; Mannino D; Anderson S; Brown R; Dolor R; Elder N; Joo M; Khan I; Knox LM; Meldrum C; Peters E; Spino C; Tapp H; Thomashow B; Zittleman L; Make B; Yawn BP;
    JAMA; 2023 Feb; 329(6):490-501. PubMed ID: 36786790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.
    Tinkelman DG; Price DB; Nordyke RJ; Halbert RJ
    J Asthma; 2006; 43(1):75-80. PubMed ID: 16448970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis.
    Fernández-Villar A; López-Campos JL; Represas Represas C; Marín Barrera L; Leiro Fernández V; López Ramírez C; Casamor R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():961-7. PubMed ID: 26028969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoke, Biomass Exposure, and COPD Risk in the Primary Care Setting: The PUMA Study.
    Montes de Oca M; Zabert G; Moreno D; Laucho-Contreras ME; Lopez Varela MV; Surmont F
    Respir Care; 2017 Aug; 62(8):1058-1066. PubMed ID: 28559464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry?
    Melbye H; Al-Ani S; Spigt M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3145-3152. PubMed ID: 27994453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of respiratory symptoms in persons with restrictive ventilatory impairment compared with persons with chronic obstructive pulmonary disease: The PLATINO study.
    Nonato NL; Nascimento OA; Padilla RP; de Oca MM; Tálamo C; Valdivia G; Lisboa C; López MV; Celli B; Menezes AM; Jardim JR
    Chron Respir Dis; 2015 Aug; 12(3):264-73. PubMed ID: 26041119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilator response of advanced lung function parameters depending on COPD severity.
    Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.